Category Archives: Regional News

You are here: Home » Category: "Regional News"

HMC HealthWorks Selects Medecision to Enhance Clinical Workflows, Utilization Management and Employee Engagement

DALLAS, Oct. 18, 2017 (GLOBE NEWSWIRE) — HMC HealthWorks, 40-year veteran in healthcare management, and Medecision, the leader in population health management solutions for risk-bearing entities, announced HMC HealthWorks has selected Medecision and its suite of Aerial applications for new, automated clinical workflows, including utilization management, which will significantly enhance the care of HMC HealthWorks’…

[Read More]

IGC-AD1 Targeting Alzheimer’s Disease to be commercialized in early 2018 Through Medical Dispensaries

BETHESDA, Md., Oct. 18, 2017 (GLOBE NEWSWIRE) — India Globalization Capital, Inc. (NYSE-MKT:IGC) provides compelling in vitro data compiled from genetically engineered cell lines within an Alzheimer’s disease model, showing that at varying concentrations of IGC-AD1 the expression of GSK3β is reduced by as much as 62%, leading in turn to a reduction in hyper…

[Read More]

Inovalon Announces Third Quarter 2017 Earnings Conference Call

BOWIE, Md., Oct. 18, 2017 (GLOBE NEWSWIRE) — Inovalon (NASDAQ:INOV), a leading technology company providing advanced, cloud-based platforms empowering a data-driven transformation from volume-based to value-based models across the healthcare ecosystem, today announced that it will hold a conference call for investors on Wednesday, November 1, 2017, at 5:00 p.m. Eastern Time. During the conference…

[Read More]

Novan Acquires IP Rights to Treat Viral Malignancies with Nitric Oxide

Expanded Indications in Field of Virology Build on SB206 Clinical Success Against Human Papillomavirus Company Doses First Patient in Inflammatory Skin Disease Program in Phase 1b Psoriasis Trial with SB414 MORRISVILLE, N.C., Oct. 18, 2017 (GLOBE NEWSWIRE) — Novan, Inc. (“the Company” or “Novan”) (NASDAQ:NOVN) today announced that it has completed a transaction with KNOW…

[Read More]

Globus Medical Schedules Third Quarter 2017 Earnings Release and Conference Call

AUDUBON, Pa., Oct. 17, 2017 (GLOBE NEWSWIRE) — Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the third quarter ended September 30, 2017 after the market close on Wednesday, November 8, 2017. A copy of the release will be available on the Globus Medical website at www.globusmedical.com/investors. Following the…

[Read More]

Optinose Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares of Common Stock

YARDLEY, Pa., Oct. 17, 2017 (GLOBE NEWSWIRE) — OptiNose, Inc. (NASDAQ:OPTN), a specialty pharmaceutical company focused on the development and commercialization of products for patients treated by ear, nose and throat (ENT) and allergy specialists, today announced the closing of its initial public offering of 8,625,000 shares of common stock at a public offering price…

[Read More]

Clinipace Worldwide Co-founder & CEO Jeff Williams to Resign as CEO

MORRISVILLE, N.C., Oct. 17, 2017 (GLOBE NEWSWIRE) — Jeff Williams, Co-founder, President, and CEO of Clinipace Worldwide, a global full-service clinical research organization (CRO) that he founded 14 years ago, has elected to move into an expanded advisory role with the company’s Board of Directors. He will be handing over his responsibilities to Jason Monteleone, who…

[Read More]

Significant advance in breast cancer care – Cohera Medical, Inc. ® Drain-Free Mastectomy trial reaches full enrollment

RALEIGH, N.C., Oct. 17, 2017 (GLOBE NEWSWIRE) — Painful post-surgical drains may become unnecessary for breast cancer patients who undergo a mastectomy procedure (removal of the breast).  A level I clinical study seeks to provide evidence that the skin flap can be adhered to the chest wall with TissuGlu Surgical Adhesive® after removal of the…

[Read More]

Quotient Limited to Report Fiscal Second Quarter 2018 Financial Results and Host Conference Call

JERSEY, Channel Islands, Oct. 17, 2017 (GLOBE NEWSWIRE) — Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal second quarter ended September 30, 2017, will be released after market close on Monday, October 30, 2017. Quotient will host a conference call on Tuesday, October 31, 2017 at 8:30 a.m. Eastern Time…

[Read More]

Diffusion Pharmaceuticals Receives Final FDA Protocol Guidance for Phase 3 Clinical Trial with TSC in Patients Newly Diagnosed with Inoperable Glioblastoma Multiforme

CHARLOTTESVILLE, Va., Oct. 17, 2017 (GLOBE NEWSWIRE) — Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) (“Diffusion” or “the Company”), a clinical-stage biotechnology company focused on extending the life expectancy of cancer patients, announced that it has received final protocol guidance from the U.S. Food and Drug Administration (FDA) for a Phase 3 clinical trial with the Company’s lead…

[Read More]